Author

Author

Sort by: Order: Results:

  • Bajpai, Aman; Desai, Nakshi; Pandey, Shalini; Shukla, Chinmayee; Datta, Bhaskar; Basu, Sudipta (Royal Society of Chemistry, 2022-01)
    Mitochondrial dysfunction is implicated in myriad diseases, including cancer. Subsequently, targeting mitochondrial DNA (mt-DNA) in cancer cells has emerged as an unorthodox strategy for anti-cancer therapy. However, ...
  • Nandi, Aditi; Ghosh, Chandramouli; Bajpai, Aman; Basu, Sudipta (Royal Society of Chemistry, 2019-05)
    DNA Topoisomerases and nuclear DNA are important targets for cancer therapy. However, DNA Topoisomerase inhibitors and DNA damaging drugs demonstrate a large window of side effects in the clinics. Graphene oxide based ...
  • Bajpai, Aman; Desai, Nakshi; Pandey, Shalini; Shukla, Chinmayee; Datta, Bhaskar; Basu, Sudipta (American Chemical Society, 2021-08)
    In recent years, antibiotics have emerged as alternative medicines in cancer therapy due to their capability of mitochondrial dysfunction in cancer cells. However, antibiotics render collateral damage in noncancerous cells ...
  • Bajpai, Aman; Deepshikha; Chhabria, Dimple; Mishra, Tripti; Kirubakaran, Sivapriya; Basu, Sudipta (Elsevier, 2022-06)
    Mitochondrion emerged as an important therapeutic target for anti-cancer strategy due to its involvement in cancer progression and development. However, progress of novel small molecules for selective targeting of mitochondria ...

Search Digital Repository


Browse

My Account